Atuliflapon, SALBUTAMOL, Placebo to Atuliflapon
D7552C00001
Phase 2 small_molecule active
Quick answer
Atuliflapon, SALBUTAMOL, Placebo to Atuliflapon for Moderate-to-Severe Uncontrolled Asthma is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Moderate-to-Severe Uncontrolled Asthma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active